Torrent Pharmaceuticals is set to acquire JB Chemicals in a landmark deal worth Rs. 19,500 crore, marking one of the largest acquisitions in India’s pharmaceutical industry. This strategic move not only strengthens Torrent’s position in the domestic branded generics market but also enhances its global footprint, particularly in regulated markets. The acquisition brings together two complementary portfolios, promising strong synergies across therapeutic areas and geographies.